Add like
Add dislike
Add to saved papers

Prevalence of Anaplasma species in India and the World in dairy animals: A systematic review and meta-analysis.

In the present study, the prevalence of Anaplasma species in diary animals from India and World was estimated using meta-analysis. Based on systematic review of studies on Anaplasma species from India [35] and World [66] from 1988 to 2017 and 1978-2017, respectively, using online databases and offline literatures, meta-analysis using meta package in R-Software was done. Prevalence of Anaplasma species in India and World were 11% [95% level, Confidence Interval[CI] 7-16%, Prediction Interval[PI] 1-69%] and 39% [95% level, CI 30-49%, PI 2-95%], and these were obtained using 31,117 and 46,365 samples, respectively. Period-wise analysis revealed high Anaplasma species prevalence before 2011 for India and the World than from 2011 through 2017. Zone-wise prevalence indicated high prevalence in Central zone [61%] and low in West and South zones [6%] in India, and continent-wise, it was high in South America [82%]. The studies used methods including blood smear examination, serology and nucleic acid-based techniques and revealed high prevalence in serology for India [34%] and World [46%], low prevalence by blood smear for India [7%] and World [21%], but higher sensitivity using nucleic acid-based techniques. Species-wise indicated higher prevalence in cattle [12%] than buffaloes [2%] in India. Prevalence was lower in India compared to the World and higher in South America. Overall, anaplasmosis causes low productivity in dairy animals and economic loss to dairy farmers. Hence, there is a need to control Anaplasma infections in high risk areas by adopting effective therapeutic and preventive measures so as to improve the economic benefits in dairy farming.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app